197 related articles for article (PubMed ID: 34929704)
41. Patient-reported outcomes in hidradenitis suppurativa.
Vellaichamy G; Braunberger TL; Jones JL; Peacock A; Nahhas AF; Hamzavi IH
G Ital Dermatol Venereol; 2019 Apr; 154(2):137-147. PubMed ID: 30375207
[TBL] [Abstract][Full Text] [Related]
42. The role of negative pressure wound therapy in the management of hidradenitis suppurativa: a case report and literature review.
Parrado R; Cadena M; Vergara A; Cadena D; Chalela JG
Int Wound J; 2017 Feb; 14(1):35-39. PubMed ID: 26663439
[TBL] [Abstract][Full Text] [Related]
43. Hidradenitis Suppurativa From a Patient Perspective Including Symptoms and Self-Treatment.
Huang CM; Kirchhof MG
J Cutan Med Surg; 2021; 25(6):591-597. PubMed ID: 34137667
[TBL] [Abstract][Full Text] [Related]
44. Pain experiences among those living with hidradenitis suppurativa: a qualitative study.
Orenstein LAV; Salame N; Siira MR; Urbanski M; Flowers NI; Echuri H; Garg A; McKenzie-Brown AM; Curseen KA; Patzer RE; Kavalieratos D; Chen SC
Br J Dermatol; 2023 Jan; 188(1):41-51. PubMed ID: 36689519
[TBL] [Abstract][Full Text] [Related]
45. Analysis of Characteristics and Trends in Treatment Response of Hidradenitis Suppurativa Patients: A Southern US Cohort Study.
Peterson GC; Preston A; Frieder J; Wang X; Paek SY
Dermatology; 2020; 236(5):413-420. PubMed ID: 31935718
[TBL] [Abstract][Full Text] [Related]
46. Baseline Characteristics of a National French E-Cohort of Hidradenitis Suppurativa in ComPaRe and Comparison with Other Large Hidradenitis Suppurativa Cohorts.
Condamina M; Penso L; Tran VT; Hotz C; Guillem P; Villani AP; Perrot P; Bru MF; Jacquet E; Nassif A; Bachelez H; Wolkenstein P; Beylot-Barry M; Richard MA; Ravaud P; Viguier M; Sbidian E
Dermatology; 2021; 237(5):748-758. PubMed ID: 33503635
[TBL] [Abstract][Full Text] [Related]
47. [Clinical therapeutic observation on sequential treatment of chronic wounds with repeated recurrence of hidradenitis suppurativa in buttocks].
Li ZQ; Wen HD; Li SL; Niu LB; Wu Q
Zhonghua Shao Shang Za Zhi; 2019 Oct; 35(10):757-760. PubMed ID: 31658548
[No Abstract] [Full Text] [Related]
48. HIDRAdisk: validation of an innovative visual tool to assess the burden of hidradenitis suppurativa.
Peris K; Lo Schiavo A; Fabbrocini G; Dini V; Patrizi A; Fusano M; Bianchi L; Guanziroli E; Guarneri C; Parodi A; Bertoldi A; Musumeci ML; Offidani A; Rongioletti F; Pistone G; Malara G; Potenza C; Casari A; Franchi C; Ardigò M; Cusano F; Stingeni L; Amerio P; Mancini LL; Prignano F; Deboli T; Gualberti G; Saragaglia V; Bettoli V
J Eur Acad Dermatol Venereol; 2019 Apr; 33(4):766-773. PubMed ID: 30633405
[TBL] [Abstract][Full Text] [Related]
49. Impact of the COVID-19 pandemic on patients with hidradenitis suppurativa.
Fiocco Z; Schlager JG; Kendziora B; Patzak L; Kupf S; French LE; Hartmann D
Int Wound J; 2022 Nov; 19(7):1686-1692. PubMed ID: 35128802
[TBL] [Abstract][Full Text] [Related]
50. Can Ultrasound Examinations Generate Pain in Hidradenitis Suppurativa Patients? Results from a Multicentric Cross-Sectional Study.
Wortsman X; Reyes-Baraona F; Ramirez-Cornejo C; Ferreira-Wortsman C; Caposiena Caro RD; Molina-Leyva A; Arias-Santiago S; Giavedoni P; Martorell A; Romani J; Gonzalez C; Alfageme F
Dermatology; 2023; 239(2):277-282. PubMed ID: 36122570
[TBL] [Abstract][Full Text] [Related]
51. Twenty-four-week interim analysis from a phase 3 open-label trial of adalimumab in Japanese patients with moderate to severe hidradenitis suppurativa.
Morita A; Takahashi H; Ozawa K; Imafuku S; Nakama T; Takahashi K; Matsuyama T; Okubo Y; Kitamura S; Matsuda N; Zhao Y; Yokoyama M; Hayashi N; Terui T
J Dermatol; 2019 Sep; 46(9):745-751. PubMed ID: 31282051
[TBL] [Abstract][Full Text] [Related]
52. A cross-sectional epidemiological study of hidradenitis suppurativa in an Irish population (SHIP).
Delany E; Gormley G; Hughes R; McCarthy S; Kirthi S; Markham T; Tobin AM; Murphy M; Kirby B
J Eur Acad Dermatol Venereol; 2018 Mar; 32(3):467-473. PubMed ID: 29125658
[TBL] [Abstract][Full Text] [Related]
53. Patient Perspectives on Hidradenitis Suppurativa and Infertility: A Survey Study.
Masson R; Shih T; Park S; De DR; Gierbolini A; Alavi A; Garg A; Micheletti RG; Shi VY; Hsiao JL
Dermatology; 2023; 239(5):732-737. PubMed ID: 37385230
[TBL] [Abstract][Full Text] [Related]
54. Surgical outcomes and the impact of major surgery on quality of life, activity impairment and sexual health in hidradenitis suppurativa patients: a prospective single centre study.
Prens LM; Huizinga J; Janse IC; Horváth B
J Eur Acad Dermatol Venereol; 2019 Oct; 33(10):1941-1946. PubMed ID: 31132177
[TBL] [Abstract][Full Text] [Related]
55. Pilonidal sinus disease: an intergluteal localization of hidradenitis suppurativa/acne inversa: a cross-sectional study among 2465 patients.
Benhadou F; Van der Zee HH; Pascual JC; Rigopoulos D; Katoulis A; Liakou AI; Daxhelet M; Romanelli M; Iannone M; Kinyó Á; Nikolakis G; Zouboulis CC; Dessinioti C; Zisimou C; Antoniou C; Alavi A; Mintoff D; Aquilina S; Matusiak L; Szepietowski JC; Sinclair R; Husein-ElAhmed H; von Laffert M; Revuz J; Danby B; Puig L; Theut Riis P; Jemec GBE; van Straalen K; Wigny KMGJ; Del Marmol V; Guillem P
Br J Dermatol; 2019 Dec; 181(6):1198-1206. PubMed ID: 30919434
[TBL] [Abstract][Full Text] [Related]
56. Reliability of the hidradenitis suppurativa clinical response in the assessment of patients with hidradenitis suppurativa.
Kimball AB; Ganguli A; Fleischer A
J Eur Acad Dermatol Venereol; 2018 Dec; 32(12):2254-2256. PubMed ID: 29959796
[TBL] [Abstract][Full Text] [Related]
57. Patient Satisfaction and Quality of Life Following Surgery for Hidradenitis Suppurativa.
Kohorst JJ; Baum CL; Otley CC; Roenigk RK; Pemberton JH; Dozois EJ; Tran NV; Davis MD
Dermatol Surg; 2017 Jan; 43(1):125-133. PubMed ID: 28027202
[TBL] [Abstract][Full Text] [Related]
58. Hidradenitis suppurativa in surgeons' practice: Prevalence and treatment approach according to the Hurley stage in Latvia.
Balcere A; Upeniece I; Snipe K; Jezupovs A
Dermatol Ther; 2021 Jan; 34(1):e14687. PubMed ID: 33331018
[TBL] [Abstract][Full Text] [Related]
59. Advanced wound management approaches in Hidradenitis Suppurativa postsurgical lesions.
Michelucci A; Janowska A; Granieri G; Margiotta FM; Morganti R; Romanelli M; Dini V
Health Sci Rep; 2023 Oct; 6(10):e1582. PubMed ID: 37822841
[TBL] [Abstract][Full Text] [Related]
60. The challenges of wound management for hidradenitis suppurativa.
Moloney S
Br J Nurs; 2022 Feb; 31(4):S34-S41. PubMed ID: 35220746
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
